Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.

<h4>Background</h4>People infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) experience a wide range of clinical manifestations, from asymptomatic and mild illness to severe illness and death, influenced by age and a variety of comorbidities. Neutralizing antibodi...

Full description

Bibliographic Details
Main Authors: Shelly Karuna, Shuying Sue Li, Shannon Grant, Stephen R Walsh, Ian Frank, Martin Casapia, Meg Trahey, Ollivier Hyrien, Leigh Fisher, Maurine D Miner, April K Randhawa, Laura Polakowski, James G Kublin, Lawrence Corey, David Montefiori, HVTN 405/HPTN 1901 Study Team
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-12-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1003868